U.S. IPO Weekly Recap: A Quiet Week Ahead Of 2018’s Final Stretch

No companies went public this past week, during the post-Thanksgiving lull.

Three healthcare deals joined the IPO calendar for next week. Messenger RNA developer Moderna (MRNA) is the week’s largest offering, aiming to raise $500 million in the biggest biotech IPO ever.

There were no new IPO filings, aside from two SPACs. Blank check company Andina Acquisition III (ANDAU) filed to raise $100 million to acquire a business in Latin America, while Chardan Healthcare Acquisition (CHACU) filed to raise $70 million as it explores a healthcare business to acquire. Therefore, what is currently in the IPO pipeline is what can go public in 2018; others will have to wait.

The IPO Index climbed 4.0% this past week, though it is still well below its level before the sell-off that began in October.

Editor’s Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks.